SAA
WST icon

Southeast Asset Advisors’s West Pharmaceutical WST Stock Holding History

Southeast Asset Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-9,855
Closed -$870K – 111
2018
Q1 		$870K Hold
9,855
– – 0.26% 49
2017
Q4 		$972K Sell
9,855
-6,780
-41% -$665K 0.29% 50
2017
Q3 		$1.6M Buy
16,635
+1,900
+13% +$172K 0.51% 28
2017
Q2 		$1.39M Buy
14,735
+2,990
+25% +$275K 0.45% 30
2017
Q1 		$959K Hold
11,745
– – 0.3% 43
2016
Q4 		$996K Buy
11,745
+10
+0.1% +$786 0.31% 40
2016
Q3 		$874K Buy
11,735
+2,445
+26% +$194K 0.29% 44
2016
Q2 		$705K Sell
9,290
-60
-0.6% -$4.37K 0.23% 54
2016
Q1 		$648K Buy
+9,350
New +$563K 0.21% 57

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Southeast Asset Advisors's WST Position: Q2 2018 in Review

Southeast Asset Advisors sold out of West Pharmaceutical (WST) in Q2 2018, closing a stake of 9,855 shares — an estimated $870K sold.

Southeast Asset Advisors first reported a position in WST in Q1 2016 and held it in 9 quarters. The position peaked at $1.6M in Q3 2017. 323 funds tracked by Wall St. Rank hold WST as of Q2 2018.

  • Southeast Asset Advisors reported no remaining West Pharmaceutical position as of Q2 2018 after selling out during the quarter.
  • Southeast Asset Advisors sold 9,855 West Pharmaceutical shares in Q2 2018, an estimated $870K.
  • Southeast Asset Advisors first reported a position in West Pharmaceutical in Q1 2016 and held it in 9 quarters.
  • Southeast Asset Advisors's West Pharmaceutical position peaked at $1.6M in Q3 2017.
  • 323 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2018.

Based on Southeast Asset Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.